These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32956567)

  • 1. Peri-complication diagnosis of hepatitis C infection: Risk factors and trends over time.
    Lapointe-Shaw L; Chung H; Sander B; Kwong JC; Holder L; Cerocchi O; Austin PC; Feld JJ
    Liver Int; 2021 Jan; 41(1):33-47. PubMed ID: 32956567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of Chronic Hepatitis B Pericomplication: Risk factors and Trends Over Time.
    Lapointe-Shaw L; Chung H; Holder L; Kwong JC; Sander B; Austin PC; Janssen HLA; Feld JJ
    Hepatology; 2021 Jun; 73(6):2141-2154. PubMed ID: 32931613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications.
    Benvegnù L; Gios M; Boccato S; Alberti A
    Gut; 2004 May; 53(5):744-9. PubMed ID: 15082595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
    Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
    Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of hepatitis C virus infection: from chronic hepatitis to cirrhosis, to hepatocellular carcinoma.
    Leone N; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):31-46. PubMed ID: 15756144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection.
    Jacobson IM; Davis GL; El-Serag H; Negro F; Trépo C
    Clin Gastroenterol Hepatol; 2010 Nov; 8(11):924-33; quiz e117. PubMed ID: 20713178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease outcomes in a cohort of women in Ireland infected by hepatitis C-contaminated anti-D immunoglobulin during 1970s.
    Garvey P; Murphy N; Flanagan P; Brennan A; Courtney G; Crosbie O; Crowe J; Hegarty J; Lee J; McIver M; McNulty C; Murray F; Nolan N; O'Farrelly C; Stewart S; Tait M; Norris S; Thornton L
    J Hepatol; 2017 Dec; 67(6):1140-1147. PubMed ID: 28843656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study.
    Carrat F; Fontaine H; Dorival C; Simony M; Diallo A; Hezode C; De Ledinghen V; Larrey D; Haour G; Bronowicki JP; Zoulim F; Asselah T; Marcellin P; Thabut D; Leroy V; Tran A; Habersetzer F; Samuel D; Guyader D; Chazouilleres O; Mathurin P; Metivier S; Alric L; Riachi G; Gournay J; Abergel A; Cales P; Ganne N; Loustaud-Ratti V; D'Alteroche L; Causse X; Geist C; Minello A; Rosa I; Gelu-Simeon M; Portal I; Raffi F; Bourliere M; Pol S;
    Lancet; 2019 Apr; 393(10179):1453-1464. PubMed ID: 30765123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication.
    van der Meer AJ; Feld JJ; Hofer H; Almasio PL; Calvaruso V; Fernández-Rodríguez CM; Aleman S; Ganne-Carrié N; D'Ambrosio R; Pol S; Trapero-Marugan M; Maan R; Moreno-Otero R; Mallet V; Hultcrantz R; Weiland O; Rutter K; Di Marco V; Alonso S; Bruno S; Colombo M; de Knegt RJ; Veldt BJ; Hansen BE; Janssen HLA
    J Hepatol; 2017 Mar; 66(3):485-493. PubMed ID: 27780714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late hepatitis B and C diagnosis in relation to disease decompensation and hepatocellular carcinoma development.
    Samji H; Yu A; Kuo M; Alavi M; Woods R; Alvarez M; Dore GJ; Tyndall M; Krajden M; Janjua NZ;
    J Hepatol; 2017 Nov; 67(5):909-917. PubMed ID: 28684103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profile and value of FIB-4 in patients with dual chronic hepatitis C and B.
    Liu CJ; Tseng TC; Yang WT; Su TH; Yang HC; Liu CH; Chen PJ; Chen DS; Kao JH
    J Gastroenterol Hepatol; 2019 Feb; 34(2):410-417. PubMed ID: 30151861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study.
    Alavi M; Law MG; Grebely J; Amin J; Hajarizadeh B; George J; Dore GJ
    J Hepatol; 2016 Nov; 65(5):879-887. PubMed ID: 27401548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
    Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
    J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma in chronic HBV-HCV co-infection is correlated to fibrosis and disease duration.
    Zampino R; Pisaturo MA; Cirillo G; Marrone A; Macera M; Rinaldi L; Stanzione M; Durante-Mangoni E; Gentile I; Sagnelli E; Signoriello G; Miraglia Del Giudice E; Adinolfi LE; Coppola N
    Ann Hepatol; 2015; 14(1):75-82. PubMed ID: 25536644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased cancer rates in patients with chronic hepatitis C.
    Nyberg AH; Sadikova E; Cheetham C; Chiang KM; Shi JX; Caparosa S; Younossi ZM; Nyberg LM
    Liver Int; 2020 Mar; 40(3):685-693. PubMed ID: 31755208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C: frequency and risk factors associated with sero-positivity among adults in Larkana City.
    Shaikh FH; Ali Abro H; Ali Chhutto M; Abbasi PA; Shaikh AW; Ali Buriro S
    J Ayub Med Coll Abbottabad; 2009; 21(2):107-9. PubMed ID: 20524483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.
    Kileng H; Bernfort L; Gutteberg T; Moen OS; Kristiansen MG; Paulssen EJ; Berg LK; Florholmen J; Goll R
    BMC Infect Dis; 2017 Sep; 17(1):624. PubMed ID: 28915795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing burden of advanced hepatocellular carcinoma in New Zealand-the need for better surveillance.
    Schauer C; Mules T; Rijnsoever MV; Gane E
    N Z Med J; 2020 May; 133(1515):25-34. PubMed ID: 32438374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.